Table 5.

Clinical outcomes analysis of group 2

	No declared delayed access n = 87 (84.5%)	Declared delayed access n = 16 (15.5%)	p-value	Crude OR (95% CI), p-value	Adjusted OR* (95% CI), p-value
Intra-operative complications, n (%)	0 (0.0)	1 (8.3)	0.13
Morbidity, n (%)	15 (18.3)	5 (41.7)		OR = 3.19 (0.89–11.44) p = 0.07	aOR = 2.31 (0.51–10.45) p = 0.28
Dindo-Clavien 0–2, n (%)	73 (89.0)	10 (83.3)	0.01	n.a.	n.a.
Dindo-Clavien 3–4, n (%)	9 (11.0)	0 (0.0)
Dindo-Clavien 5, n (%)	0 (0.0)	2 (16.7)
Blood transfusions, n (%)	5 (6.10)	3 (25.0)		OR = 5.13 (1.05–25.15) p = 0.04	aOR = 3.70 (0.63–21.60) p = 0.15
30-day mortality, n (%)	2 (2.4)	2 (16.7)		OR = 8.00 (1.01–63.23) p = 0.05	aOR = 3.65 (0.24–54.69) p = 0.35
Stoma**	3 (6.5)	1 (10.0)		1.59 (0.15–17.1) p = 0.70	aOR = 1.11 (0.07–18.52) p = 0.94

aOR adjusted odds ratio, CI confidence interval, OR odds ratio

*Adjusted for ASA score, age, CCI and NEWS

**Only for operations performed in General Surgery Units